Antitauon (2027)

Stopping tau proteins from sticking together to form toxic seeds.

The concept of "tauons" arises from the observation that misfolded tau protein isoforms can propagate through the brain in a characteristic pattern, similar to prions, driving the progression of conditions like Alzheimer's disease. Antitauon therapies aim to intervene in this process through several key mechanisms: antitauon

In the context of neurodegenerative research, "antitauons" refer to or therapeutic agents designed to neutralize tauons —the prion-like, pathological forms of the tau protein that spread from neuron to neuron. Overview of Tauons and Antitauons Stopping tau proteins from sticking together to form

Vaccines that stimulate the patient's own immune system to produce anti-tau antibodies. , ACI-35 Intracellular Targeting Overview of Tauons and Antitauons Vaccines that stimulate

While many antitauon therapies have reached clinical trials, results have been mixed:

Current research focuses on both to combat these tauon species: Example Agents / Trials Passive Immunotherapy

Administration of lab-made monoclonal antibodies (mAbs) to target specific tau epitopes. , Semorinemab , Gosuranemab Active Immunotherapy